{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:02:05Z","timestamp":1762671725726},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T00:00:00Z","timestamp":1218240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00198-008-0711-2","type":"journal-article","created":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T08:38:13Z","timestamp":1218184693000},"page":"585-597","source":"Crossref","is-referenced-by-count":34,"title":["Mapping the prescriptiome to fractures in men\u2014a national analysis of prescription history and fracture risk"],"prefix":"10.1007","volume":"20","author":[{"given":"B.","family":"Abrahamsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Brixen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,9]]},"reference":[{"issue":"Suppl 2","key":"711_CR1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s00198-004-1702-6","volume":"16","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3\u2013S7","journal-title":"Osteoporos Int"},{"key":"711_CR2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0025-6196(11)62214-3","volume":"77","author":"LA Fitzpatrick","year":"2002","unstructured":"Fitzpatrick LA (2002) Secondary causes of osteoporosis. Mayo Clin Proc 77:453\u2013468","journal-title":"Mayo Clin Proc"},{"key":"711_CR3","first-page":"28","volume":"101","author":"N Binkley","year":"2002","unstructured":"Binkley N, Krueger D (2002) Osteoporosis in men. WMJ 101:28\u201332","journal-title":"WMJ"},{"key":"711_CR4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1359\/jbmr.1999.14.3.342","volume":"14","author":"PR Ebeling","year":"1999","unstructured":"Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP (1999) Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 14:342\u2013350","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"711_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02207246","volume":"8","author":"T Bardin","year":"1989","unstructured":"Bardin T, Lequesne M (1989) The osteoporosis of heparinotherapy and systemic mastocytosis. Clin Rheumatol 8(Suppl 2):119\u2013123","journal-title":"Clin Rheumatol"},{"key":"711_CR6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00198-005-1892-6","volume":"17","author":"LA Ahmed","year":"2006","unstructured":"Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RM (2006) Self-reported diseases and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 17:46\u201353","journal-title":"Osteoporos Int"},{"key":"711_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/105072502760043503","volume":"12","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411\u2013419","journal-title":"Thyroid"},{"key":"711_CR8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","volume":"45","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of antiepileptic drugs. Epilepsia 45:1330\u20131337","journal-title":"Epilepsia"},{"key":"711_CR9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-200730020-00006","volume":"30","author":"B Takkouche","year":"2007","unstructured":"Takkouche B, Montes-Martinez A, Gill SS, Etminan M (2007) Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 30:171\u2013184","journal-title":"Drug Saf"},{"key":"711_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10401230500464687","volume":"18","author":"JM Meyer","year":"2006","unstructured":"Meyer JM, Lehman D (2006) Bone mineral density in male schizophrenia patients: a review. Ann Clin Psychiatry 18:43\u201348","journal-title":"Ann Clin Psychiatry"},{"key":"711_CR11","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","volume":"23","author":"PE Lonning","year":"2005","unstructured":"Lonning PE, Geisler J, Krag LE, Erikstein B, Bremnes Y, Hagen AI, Schlichting E, Lien EA, Ofjord ES, Paolini J, Polli A, Massimini G (2005) Effects of exemestane administered for 2\u00a0years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol 23:5126\u20135137","journal-title":"J Clin Oncol"},{"issue":"4","key":"711_CR12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-410X.2007.07163.x","volume":"100","author":"B Abrahamsen","year":"2007","unstructured":"Abrahamsen B, Frost MM, Walther S, Brixen K (2007) Fracture risk in patients with prostate cancer. A nationwide case-control study. Br J Urol 100(4):749\u2013754","journal-title":"Br J Urol"},{"key":"711_CR13","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","volume":"91","author":"AV Schwartz","year":"2006","unstructured":"Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR (2006) Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 91:3349\u20133354","journal-title":"J Clin Endocrinol Metab"},{"key":"711_CR14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s002239900288","volume":"61","author":"NI Paton","year":"1997","unstructured":"Paton NI, Macallan DC, Griffin GE, Pazianas M (1997) Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 61:30\u201332","journal-title":"Calcif Tissue Int"},{"issue":"7153","key":"711_CR15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06010","volume":"448","author":"H Hakonarson","year":"2007","unstructured":"Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT, Grabs R, Casalunovo T, Taback SP, Frackelton EC, Lawson ML, Robinson LJ, Skraban R, Lu Y, Chiavacci RM, Stanley CA, Kirsch SE, Rappaport EF, Orange JS, Monos DS, Devoto M, Qu HQ, Polychronakos C (2007) A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448(7153):591\u2013594","journal-title":"Nature"},{"key":"711_CR16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254\u20131259","journal-title":"BMJ"},{"key":"711_CR17","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00198-006-0135-9","volume":"17","author":"JA Pasco","year":"2006","unstructured":"Pasco JA, Seeman E, Henry MJ, Merriman EN, Nicholson GC, Kotowicz MA (2006) The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int 17:1404\u20131409","journal-title":"Osteoporos Int"},{"key":"711_CR18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"711_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"711_CR20","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/1475-6773.00165","volume":"38","author":"S Schneeweiss","year":"2003","unstructured":"Schneeweiss S, Wang PS, Avorn J, Glynn RJ (2003) Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res 38:1103\u20131120","journal-title":"Health Serv Res"},{"key":"711_CR21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9:811\u2013818","journal-title":"Stat Med"},{"key":"711_CR22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 79:76\u2013783","journal-title":"Calcif Tissue Int"},{"key":"711_CR23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1532-5415.2001.49280.x","volume":"49","author":"PS Wang","year":"2001","unstructured":"Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J (2001) Zolpidem use and hip fractures in older people. J Am Geriatr Soc 49:1685\u20131690","journal-title":"J Am Geriatr Soc"},{"key":"711_CR24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","volume":"17","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807\u2013816","journal-title":"Osteoporos Int"},{"key":"711_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM198702123160702","volume":"316","author":"WA Ray","year":"1987","unstructured":"Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ III (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316:363\u2013369","journal-title":"N Engl J Med"},{"key":"711_CR26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/01.jcp.0000145344.76288.39","volume":"24","author":"S Schneeweiss","year":"2004","unstructured":"Schneeweiss S, Wang PS (2004) Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 24:632\u2013638","journal-title":"J Clin Psychopharmacol"},{"key":"711_CR27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(97)09528-7","volume":"351","author":"B Liu","year":"1998","unstructured":"Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303\u20131307","journal-title":"Lancet"},{"key":"711_CR28","doi-asserted-by":"crossref","first-page":"M111","DOI":"10.1093\/geronj\/47.4.M111","volume":"47","author":"RI Shorr","year":"1992","unstructured":"Shorr RI, Griffin MR, Daugherty JR, Ray WA (1992) Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol 47:M111\u2013M115","journal-title":"J Gerontol"},{"key":"711_CR29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2796.2006.01667.x","volume":"260","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with the use of morphine and opiates. J Intern Med 260:76\u201387","journal-title":"J Intern Med"},{"key":"711_CR30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00223-006-0020-8","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int 79:84\u201394","journal-title":"Calcif Tissue Int"},{"key":"711_CR31","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1532-5415.2005.53464.x","volume":"53","author":"HA Fink","year":"2005","unstructured":"Fink HA, Kuskowski MA, Orwoll ES, Cauley JA, Ensrud KE (2005) Association between Parkinson\u2019s disease and low bone density and falls in older men: the osteoporotic fractures in men study. J Am Geriatr Soc 53:1559\u20131564","journal-title":"J Am Geriatr Soc"},{"key":"711_CR32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00198-008-0583-5","volume":"19","author":"JL Schneider","year":"2008","unstructured":"Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR (2008) The association of Parkinson\u2019s disease with bone mineral density and fracture in older women. Osteoporos Int 19:1093\u20131097. doi: 10.1007\/s00198-008-0583-5","journal-title":"Osteoporos Int"},{"key":"711_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","volume":"259","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with loop diuretics. J Intern Med 259:117\u2013124","journal-title":"J Intern Med"},{"key":"711_CR34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ageing\/afi133","volume":"34","author":"LS Lim","year":"2005","unstructured":"Lim LS, Fink HA, Kuskowski MA, Cauley JA, Ensrud KE (2005) Diuretic use and bone mineral density in older USA men: the osteoporotic fractures in men (MrOS) study. Age Ageing 34:504\u2013507","journal-title":"Age Ageing"},{"issue":"10","key":"711_CR35","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00198-007-0386-0","volume":"18","author":"U Sennerby","year":"2007","unstructured":"Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaelsson K (2007) Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 18(10):1355\u20131362","journal-title":"Osteoporos Int"},{"key":"711_CR36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00198-003-1398-z","volume":"14","author":"F Richy","year":"2003","unstructured":"Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer JP, Peel N, Haim M, Bruyere O, Reginster JY (2003) Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 14:179\u2013190","journal-title":"Osteoporos Int"},{"key":"711_CR37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2796.2006.01754.x","volume":"261","author":"F Vries de","year":"2007","unstructured":"de Vries F, Pouwels S, Lammers JW, Leufkens HG, Bracke M, Cooper C, van Staa TP (2007) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip\/femur fracture: a population-based case-control study. J Intern Med 261:170\u2013177","journal-title":"J Intern Med"},{"key":"711_CR38","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/jpet.106.105437","volume":"318","author":"N Bonnet","year":"2006","unstructured":"Bonnet N, Laroche N, Vico L, Dolleans E, Benhamou CL, Courteix D (2006) Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther 318:1118\u20131127","journal-title":"J Pharmacol Exp Ther"},{"key":"711_CR39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bone.2007.01.006","volume":"40","author":"N Bonnet","year":"2007","unstructured":"Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, Benhamou CL (2007) Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. Bone 40:1209\u20131216","journal-title":"Bone"},{"key":"711_CR40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 24:581\u2013589","journal-title":"J Hypertens"},{"key":"711_CR41","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00198-007-0354-8","volume":"18","author":"C Meisinger","year":"2007","unstructured":"Meisinger C, Heier M, Lang O, Doring A (2007) Beta-blocker use and risk of fractures in men and women from the general population: the MONICA\/KORA Augsburg cohort study. Osteoporos Int 18:1189\u20131195","journal-title":"Osteoporos Int"},{"key":"711_CR42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-004-0222-x","volume":"75","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Vestergaard P, Kassem M, Christoffersen BR, Kolthoff N, Brixen K, Mosekilde L (2004) Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int 75:365\u2013372","journal-title":"Calcif Tissue Int"},{"key":"711_CR43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00223-006-0213-1","volume":"80","author":"F Vries de","year":"2007","unstructured":"de Vries F, Souverein PC, Cooper C, Leufkens HGM, van Staa TP (2007) Use of beta-blockers and the risk of hip\/femur fracture in the United Kingdom and the Netherlands. Calcif Tissue Int 80:69\u201375","journal-title":"Calcif Tissue Int"},{"key":"711_CR44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00198-005-0011-z","volume":"17","author":"V Ferencz","year":"2006","unstructured":"Ferencz V, Meszaros S, Csupor E, Toth E, Bors K, Falus A, Horvath C (2006) Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy. Osteoporos Int 17:484\u2013491","journal-title":"Osteoporos Int"},{"key":"711_CR45","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/S0022-5347(05)65060-4","volume":"167","author":"RW Ross","year":"2002","unstructured":"Ross RW, Small EJ (2002) Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. J Urol 167:1952\u20131956","journal-title":"J Urol"},{"key":"711_CR46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/jnci\/djj230","volume":"98","author":"VB Shahinian","year":"2006","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS (2006) Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst 98:839\u2013845","journal-title":"J Natl Cancer Inst"},{"key":"711_CR47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urology.2006.11.002","volume":"69","author":"J Morote","year":"2007","unstructured":"Morote J, Morin JP, Orsola A, Abascal JM, Salvador C, Trilla E, Raventos CX, Cecchini L, Encabo G, Reventos J (2007) Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer. Urology 69:500\u2013504","journal-title":"Urology"},{"key":"711_CR48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(05)00033-9","volume":"175","author":"MR Smith","year":"2006","unstructured":"Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J (2006) Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol 175:136\u2013139","journal-title":"J Urol"},{"key":"711_CR49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00198-004-1799-7","volume":"16","author":"AM Lopez","year":"2005","unstructured":"Lopez AM, Pena MA, Hernandez R, Val F, Martin B, Riancho JA (2005) Fracture risk in patients with prostate cancer on androgen deprivation therapy. Osteoporos Int 16:707\u2013711","journal-title":"Osteoporos Int"},{"key":"711_CR50","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","volume":"48","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292\u20131299","journal-title":"Diabetologia"},{"key":"711_CR51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00198-003-1387-2","volume":"14","author":"MK Clark","year":"2003","unstructured":"Clark MK, Sowers MF, Dekordi F, Nichols S (2003) Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery. Osteoporos Int 14:396\u2013403","journal-title":"Osteoporos Int"},{"key":"711_CR52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1359\/JBMR.050202","volume":"20","author":"RA Dhonukshe-Rutten","year":"2005","unstructured":"Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA (2005) Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20:921\u2013929","journal-title":"J Bone Miner Res"},{"key":"711_CR53","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.293.9.1082","volume":"293","author":"Y Sato","year":"2005","unstructured":"Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on Hip fractures in patients with stroke\u2014a randomized controlled trial. JAMA 293:1082\u20131088","journal-title":"JAMA"},{"key":"711_CR54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10534-006-9000-8","volume":"19","author":"ED Weinberg","year":"2006","unstructured":"Weinberg ED (2006) Iron loading: a risk factor for osteoporosis. Biometals 19:633\u2013635","journal-title":"Biometals"},{"key":"711_CR55","unstructured":"The European Agency for the Evaluation of Medicinal Products. Points to consider on multiplicity issues in clinical trials, EMEA CPMP\/EWP\/908\/99, London 2002). 2008; EMEA CPMP\/EWP\/908\/99"},{"key":"711_CR56","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ije\/dyl147","volume":"35","author":"F Vries de","year":"2006","unstructured":"de Vries F, de Vries C, Cooper C, Leufkens B, van Staa TP (2006) Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J of Epid 35:1301\u20131308","journal-title":"Int J of Epid"},{"key":"711_CR57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2006.07.022","volume":"118","author":"L Rejnmark","year":"2007","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2007) Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol 118:338\u2013344","journal-title":"Int J Cardiol"},{"key":"711_CR58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00198-003-1548-3","volume":"15","author":"M Steinbuch","year":"2004","unstructured":"Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15:323\u2013328","journal-title":"Osteoporos Int"},{"key":"711_CR59","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP Staa van","year":"2003","unstructured":"van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224\u20133229","journal-title":"Arthritis Rheum"},{"key":"711_CR60","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2796.2003.01219.x","volume":"254","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Olsen ML, Paaske JS, Rejnmark L, Sorensen HT, Mosekilde L (2003) Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med 254:486\u2013493","journal-title":"J Intern Med"},{"key":"711_CR61","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP Staa van","year":"2006","unstructured":"van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104\u20133112","journal-title":"Arthritis Rheum"},{"key":"711_CR62","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/oxfordjournals.aje.a009171","volume":"145","author":"JA Grisso","year":"1997","unstructured":"Grisso JA, Kelsey JL, O\u2019Brien LA, Miles CG, Sidney S, Maislin G, LaPann K, Moritz D, Peters B (1997) Risk factors for hip fracture in men. Hip Fracture Study Group. Am J Epidemiol 145:786\u2013793","journal-title":"Am J Epidemiol"},{"key":"711_CR63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS (2005) Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352:154\u2013164","journal-title":"N Engl J Med"},{"key":"711_CR64","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1212\/01.wnl.0000210503.89488.88","volume":"66","author":"PC Souverein","year":"2006","unstructured":"Souverein PC, Webb DJ, Weil JG, van Staa TP, Egberts AC (2006) Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 66:1318\u20131324","journal-title":"Neurology"},{"key":"711_CR65","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","volume":"112","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk\u2014a meta-analysis. Acta Neurol Scand 112:277\u2013286","journal-title":"Acta Neurol Scand"},{"key":"711_CR66","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0404.1999.tb00675.x","volume":"99","author":"P Vestergaard","year":"1999","unstructured":"Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L (1999) Fracture risk is increased in epilepsy. Acta Neurol Scand 99:269\u2013275","journal-title":"Acta Neurol Scand"},{"key":"711_CR67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0004-9514(06)70058-7","volume":"52","author":"JS Teo","year":"2006","unstructured":"Teo JS, Briffa NK, Devine A, Dhaliwal SS, Prince RL (2006) Do sleep problems or urinary incontinence predict falls in elderly women? Aust J Physiother 52:19\u201324","journal-title":"Aust J Physiother"},{"key":"711_CR68","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1532-5415.2005.53304.x","volume":"53","author":"AY Avidan","year":"2005","unstructured":"Avidan AY, Fries BE, James ML, Szafara KL, Wright GT, Chervin RD (2005) Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 53:955\u2013962","journal-title":"J Am Geriatr Soc"},{"key":"711_CR69","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/archinte.1991.00400040096021","volume":"151","author":"WA Ray","year":"1991","unstructured":"Ray WA, Griffin MR, Malcolm E (1991) Cyclic antidepressants and the risk of hip fracture. Arch Intern Med 151:754\u2013756","journal-title":"Arch Intern Med"},{"key":"711_CR70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/aje\/kwg114","volume":"158","author":"R Hubbard","year":"2003","unstructured":"Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A (2003) Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158:77\u201384","journal-title":"Am J Epidemiol"},{"key":"711_CR71","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archinte.159.5.484","volume":"159","author":"MA Whooley","year":"1999","unstructured":"Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS (1999) Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:484\u2013490","journal-title":"Arch Intern Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-008-0711-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-008-0711-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-008-0711-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:00:58Z","timestamp":1558638058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-008-0711-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,9]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s00198-008-0711-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,9]]}}}